Principal-led advisory at the intersection of healthcare operations and AI — for operators navigating the transformation, technology leaders building through it, and PE firms underwriting both.
Why Partners Choose BluCascadia
Most advisory firms enter each engagement from scratch. BluCascadia is built on cumulative operating experience across the healthcare spectrum, real-time market intelligence powered by a proprietary AI Intelligence Engine, and access to hundreds of healthcare IT specialists cultivated over 40 years in the industry.
Our partners are PE firms, healthcare operators, and technology leaders who need advisors that have actually run companies at scale — across founder stage, enterprise growth, and board governance. We bring 40 years of combined operating experience across the healthcare spectrum, active board seats and CEO advisory relationships at operating companies, a proprietary Intelligence Engine that monitors your competitive landscape in real-time, and direct access to domain experts who can execute on tactical diligence, technical assessment, and market validation.
We don't just advise on AI's impact on healthcare operations. We live it.
Our Intelligence Engine is a working example of how to architect, deploy, and scale AI for domain intelligence in a regulated industry. When we advise on AI monetization, technology strategy, or competitive positioning, we're drawing from direct implementation experience — not theory.
The result: PE diligence in 2–3 weeks instead of months. Strategic clarity for operators navigating AI transformation. Board-level counsel from people who've been in the chair. And when you need guidance on AI product strategy, vendor evaluation, or competitive response, you're working with advisors who've actually built and deployed these systems.
You're navigating an AI transformation with no clear roadmap.
We translate AI potential into executable strategy grounded in operational reality.
You're scaling through an inflection point in a market AI is rewriting.
We bring both sides of the table — founder experience, enterprise scale, and board perspective.
You need diligence depth and market intelligence at PE speed.
We deliver principal-led analysis backed by a real-time AI intelligence system.
About BluCascadia
BluCascadia Advisors was founded on a straightforward observation: the most consequential decisions being made in healthcare right now sit at the intersection of operations and AI — and almost no one advising on those decisions has actually operated inside both.
Most advisory firms approach healthcare AI from one of two directions: technology consultants who understand AI but have never run a healthcare organization, or healthcare operators who've watched AI from a distance and now claim expertise they haven't earned. Neither is adequate for what the market actually needs.
BluCascadia is built differently — founded by a five-time healthcare IT CEO and President with a Computer Science background, active board governance at operating companies, and a working AI intelligence system designed and deployed in-house. The firm operates at the intersection by design, not by positioning.
Our coverage spans the healthcare spectrum — acute, ambulatory, post-acute, payer, and RCM — at every operating scale from early-stage startup to $400M enterprise. Our Intelligence Engine monitors 60+ healthcare IT companies in real time. And our advisory relationships include PE firms underwriting the transformation, operators navigating it, and founders building through it.
We maintain a deliberately limited engagement roster. That's not a marketing line — it's how principal-level attention on every mandate stays possible.
BluCascadia. Operating Intelligence at Scale. Across the Healthcare Spectrum.
One engagement. One use case. The same intelligence infrastructure applies across operator strategy, competitive positioning, and technology assessment.
IE2 in Practice
A traditional consulting process to reach equivalent coverage — market scoping, interview design, scheduling, synthesis — runs eight to twelve weeks. IE2 closed that gap to twelve days.
Post-Acute Workforce Technology — Q1 2026. All identifiers removed.
PE Interest Detected
Three separate institutional investors, detected independently, all circling the same target within a 90-day window. No press release surfaces a funding conversation in progress.
Roadmap Ahead of Reality
A product demo transcript, auto-ingested from a Fireflies call, revealed the company pitching a capability to prospective clients that wasn't built yet. No management team volunteers that.
Competitive Window Narrowing
IE2's displacement tracking showed the company losing share-of-attention to AI-native competitors — faster-moving players with more capital and earlier product momentum.
The diligence team didn't enter management conversations with a blank slate. They arrived with a pre-formed thesis — which questions to lead with, which claims to pressure-test, where the real risk register lived.
12 days
Signal to standing investment file
60+
Healthcare IT companies monitored in real-time
8–12 wks
Traditional consulting equivalent
3
Independent signals surfaced before any public disclosure
The Intelligence Engine
Most advisory firms cite AI. BluCascadia operates one. Our Intelligence Engine is purpose-built on healthcare IT and AI market dynamics — continuously trained on competitive signals, operator performance patterns, and sector-specific intelligence that no general-purpose system accumulates on its own.
The result is an advisory capability that accelerates PE diligence, sharpens operator strategy, surfaces competitive positioning, and builds execution-ready frameworks — in days, not weeks.
IE2 is the current generation; IE3 is in active development.
Market signal to investment thesis in days, not weeks.
Company-specific SWOT, competitive positioning, and market response.
90-day execution frameworks grounded in real market intelligence.
AI product evaluation, build vs. buy analysis, vendor landscape mapping.
Advisory Services
Healthcare AI strategy for operators, technology leaders, and boards.
Health systems, post-acute operators, payer orgs, RCM functions, healthcare IT leadership teams
Learn more →Buy-side diligence. Market thesis. Portfolio AI strategy.
PE firms, $500M–$10B AUM
Learn more →Scaling strategy. AI product positioning. Growth inflection.
Healthcare IT founders and CEOs, Series B+
Learn more →Operator perspective on AI, market dynamics, and healthcare IT transformation.
Healthcare IT conferences, PE forums, health system leadership teams, portfolio company boards
Invite Scott to Speak →Track Record
A five-time CEO and President across the healthcare IT spectrum — including two founding roles that scaled to $40M ARR and executive leadership of enterprise EMR companies from $150M to $400M in revenue. That operating range spans acute, ambulatory, post-acute, payer, and RCM, at both founder velocity and enterprise discipline.
A Computer Science background with hands-on AI development experience, including the design and deployment of BluCascadia's proprietary Intelligence Engine — now in its second generation, with a third in active development.
Currently serving as Independent Board Member at Advanced RevCycle and Leading Reach, and as Strategic Advisor to early-stage digital health CEOs navigating AI integration and growth inflection.
Perspectives
Insights on AI monetization, healthcare IT market dynamics, and private equity strategy — drawn from active engagements, not industry reports.
March 31, 2026
Everyone's modeling 300-500 bps margin expansion from RCM automation. The data shows the opposite: the platforms chasing automation are the ones watching margins collapse. Here's why — and what it means for diligence.
Read →Coming Soon
Three structural shifts are reshaping post-acute care technology — consolidation, AI adoption, and operator pressure on margins. Understanding them changes how you invest, how you build, and how you compete.
Coming Soon
The traits that predict success in healthcare IT leadership aren't what most hiring processes test for — and aren't what most reference calls surface. A framework built on 40 years of operating experience across the healthcare spectrum.
Engagements
BluCascadia maintains a deliberately limited engagement roster to ensure principal-level attention on every mandate. If your timeline aligns, we'd welcome a brief conversation.